OGN - Organon & Co.

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
6,174,000
6,174,000
6,304,000
8,096,000
7,777,000
Cost of revenue
2,294,000
2,294,000
2,382,000
3,347,000
2,274,000
Gross profit
3,880,000
3,880,000
3,922,000
4,749,000
5,503,000
Operating expenses
Research development
471,000
471,000
443,000
304,000
220,000
Selling general and administrative
1,704,000
1,704,000
1,668,000
1,666,000
1,443,000
Total operating expenses
2,175,000
2,175,000
2,111,000
1,970,000
1,663,000
Operating income or loss
1,705,000
1,705,000
1,811,000
2,779,000
3,840,000
Interest expense
422,000
422,000
258,000
-
0
Total other income/expenses net
-161,000
-161,000
-282,000
-99,000
-144,000
Income before tax
1,122,000
1,122,000
1,529,000
2,680,000
3,696,000
Income tax expense
205,000
205,000
178,000
520,000
390,000
Income from continuing operations
917,000
917,000
1,351,000
2,160,000
3,306,000
Net income
917,000
917,000
1,351,000
2,160,000
3,218,000
Net income available to common shareholders
917,000
917,000
1,351,000
2,160,000
3,218,000
Basic EPS
-
3.61
5.33
8.53
12.71
Diluted EPS
-
3.59
5.31
8.53
12.71
Basic average shares
-
254,082
253,538
253,130
253,130
Diluted average shares
-
255,169
254,193
253,130
253,130
EBITDA
-
1,544,000
1,811,000
2,936,000
4,029,000